Skip to main content
Clinical Trials/NCT01881802
NCT01881802UnknownNot Applicable

Study of Opioid Immunosuppressive Effects

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University0 sites50 target enrollmentStarted: March 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
50
Primary Endpoint
real-time quantitative polymerase chain reaction

Study Overview

Brief Summary

This trial aims to investigate the effects of opioid-inducing immune suppression on opioid drug abused patients. The methods of the investigators research mainly includes the expression of morphine-related miRNAs in peripheral blood mononuclear cells and cytokine in plasma.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • subjects were excluded if they had a chronic systemic illness (cardiac, renal, pulmonary, hepatic, endocrine, metabolic, or autoimmune disorders) or
  • a major psychiatric disorder or
  • if they were abusing substances other than heroin (as determined by urine drug test result). For women, pregnancy was also a reason for exclusion.

Exclusion Criteria

  • Control subjects with no history of drug or alcohol abuse were also excluded if they had
  • major medical or psychiatric disorders

Outcomes

Primary Outcomes

real-time quantitative polymerase chain reaction

Time Frame: up to 2 months

Secondary Outcomes

  • enzyme-linked immuno sorbent assay(up to 2 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xiaohong Long

doctoral candidate

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Similar Trials